Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 19 min ago
PreprintCC BY-NCbioRxiv

Polyclonal sensory neuron derivation from iPSCs as an efficient alternative to single clone strategies for pain relevant in vitro models

  1. 1Uniklinik RWTH Aachen

Abstract

Induced pluripotent stem cell (iPSC) workflows typically rely on monoclonal cultures, requiring multiple independent cell lines to compensate for clonal variability. This increases workload, cost, and limits scalability for translational applications. Here, we establish polyclonal reprogramming strategies using Sendai virus to generate clonally diverse iPSC cultures already during reprogramming through FACS, MACS, manual selection, or prolonged culture. Both monoclonal and FACS-derived polyclonal cultures reached pluripotency. Reprogramming transgenes were silenced, whereas Sendai virus (SeV) mRNA persisted across passages in both culture types; heat treatment at 38.5C markedly reduced SeV levels. Monoclonal and polyclonal cultures differentiated efficiently into neural crest-like cells and sensory neurons. As a second polyclonal strategy, monoclonal cultures were pooled at day5 of sensory neuron differentiation to generate percentage-controlled progenitor mixtures. TRPA1 protein expression has not been shown reliably in iPS-derived sensory neurons. We hypothesized that increased clonal diversity might facilitate detection of TRPA1 protein expression. Despite rigorous antibody validation, TRPA1 protein expression was detectable only diffusely across the whole cell area. Together, our results show that polyclonal iPSC strategies enable clonally inclusive generation of patient-specific sensory neurons. These workflows reduce early workload and provide a robust foundation for scalable drug-screening and patient-in-a-dish applications.

Related

  1. Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies
    Flavia Lambertucci, David Skurnik, Damien Roux +4
    Cell StressPeer-reviewedCC BY 4.0Full textGeneral biologyHAL
  2. First case of three-way multiple herbicide resistance in Amaranthus palmeri outside the Americas: Resistance mechanisms and alternative management strategies
    M. Matzrafi, J. Abu-Nassar, A. Paporisch
    bioRxivPreprintCC BY-NC-NDFull textPlant biologybioRxiv
  3. Genetic organization and mobile-element basis of β-lactam resistance in a polyclonal respiratory Haemophilus influenzae population
    Xiaomei Xu, Yupeng Luo, Juntao Tan +3
    Frontiers in microbiologyPeer-reviewedCC BYFull textMicrobiologyEurope PMC
  4. 777 High-throughput discovery of rare, functionally potent antigen-reactive TCRs via polyclonal library screening
    Srishti Gupta, Miao Li, Pooja Vaikari +3
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  5. StitchR-based dual-AAV delivery strategies enable efficient transduction of defined neural cell populations.
    Nengsong Luo, Yunling Gao, Zengpeng Han +3
    Molecular brainPeer-reviewedCC BYFull textGenetics & genomicsEurope PMCDOAJ
BibTeX
@misc{neureiter2026polyclonal,
  title = {{Polyclonal sensory neuron derivation from iPSCs as an efficient alternative to single clone strategies for pain relevant in vitro models}},
  author = {A. Neureiter and L. Ruessmann and P. Hautvast and N. W. M. van den Braak and A. Stoppe and M. Haeusler and A. Lischka and K. Eggermann and A. Lampert},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.08.750017},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.08.750017v1},
  note = {CC BY-NC},
}
RIS
TY  - UNPB
TI  - Polyclonal sensory neuron derivation from iPSCs as an efficient alternative to single clone strategies for pain relevant in vitro models
AU  - A. Neureiter
AU  - L. Ruessmann
AU  - P. Hautvast
AU  - N. W. M. van den Braak
AU  - A. Stoppe
AU  - M. Haeusler
AU  - A. Lischka
AU  - K. Eggermann
AU  - A. Lampert
PY  - 2026
DA  - 2026/09/08
PB  - bioRxiv
DO  - 10.64898/2026.09.08.750017
UR  - https://www.biorxiv.org/content/10.64898/2026.09.08.750017v1
AB  - Induced pluripotent stem cell (iPSC) workflows typically rely on monoclonal cultures, requiring multiple independent cell lines to compensate for clonal variability. This increases workload, cost, and limits scalability for translational applications. Here, we establish polyclonal reprogramming strategies using Sendai virus to generate clonally diverse iPSC cultures already during reprogramming through FACS, MACS, manual selection, or prolonged culture. Both monoclonal and FACS-derived polyclonal cultures reached pluripotency. Reprogramming transgenes were silenced, whereas Sendai virus (SeV) mRNA persisted across passages in both culture types; heat treatment at 38.5C markedly reduced SeV levels. Monoclonal and polyclonal cultures differentiated efficiently into neural crest-like cells and sensory neurons. As a second polyclonal strategy, monoclonal cultures were pooled at day5 of sensory neuron differentiation to generate percentage-controlled progenitor mixtures. TRPA1 protein expression has not been shown reliably in iPS-derived sensory neurons. We hypothesized that increased clonal diversity might facilitate detection of TRPA1 protein expression. Despite rigorous antibody validation, TRPA1 protein expression was detectable only diffusely across the whole cell area. Together, our results show that polyclonal iPSC strategies enable clonally inclusive generation of patient-specific sensory neurons. These workflows reduce early workload and provide a robust foundation for scalable drug-screening and patient-in-a-dish applications.
ER  -